Investor Relations Overview
Printer Friendly Version Print | E-mail this page E-mail | E-mail Alerts Alerts | View contacts Contacts | Download Financial Tear Sheet Tear Sheet
Webcast ImageWebcast
CryoLife, Inc. at Piper Jaffray Healthcare Conference  (Live)
12/03/14 at 1:30 p.m. ET
Fortune Small Business
Congratulates CryoLife for making the 2009 hot list of the fastest-growing firms in America!
More>>

Corporate Profile

Founded in 1984, CryoLife, Inc. is a leader in medical device manufacturing and distribution and in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries.  It operates throughout the U.S. and internationally.  CryoLife manufactures and distributes BioGlue® Surgical Adhesive, an FDA-approved adjunct to sutures and staples for use in adult patients in open surgical repair of large vessels.  BioGlue is also CE marked in Europe for use in soft tissue repair and has received additional marketing approvals in several other countries throughout the world.  CryoLife’s BioFoam® Surgical Matrix is CE marked in Europe for use as an adjunct in the sealing of abdominal parenchymal tissues (liver and spleen) when cessation of bleeding by ligature or other conventional methods is ineffective or impractical.  CryoLife distributes PerClot®, an absorbable powdered hemostat, in Europe and other select international countries.  CryoLif  More >>

CRY (Common Stock)
ExchangeNYSE (US Dollar)
Price$10.12
Change (%) Stock is Up 0.10 (1.00%)
Volume55,582
11/26/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Annual Meeting Materials
2009 Annual Report - Adobe PDF2013 Annual Report
Proxy Statement and Notice of Annual Meeting - Adobe PDFProxy Statement and Notice of Annual Meeting
Proxy Card - Adobe PDFProxy Card
Recent NewsMore >>
DateTitle
11/24/14CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference
11/13/14CryoLife to Present at the Canaccord Genuity 2014 Medical Technology and Diagnostics Forum
10/28/14CryoLife Third Quarter 2014 Revenues Increase 2 Percent to $37.1 Million
Reconciliation for Certain Items
DownloadTitle
Non-GAAP Reconciliation of Free Cash Flow
Non-GAAP Reconciliation of Adjusted Net Income
Upcoming EventsMore >>
DateTitle
12/03/14 1:30 p.m. ET
CryoLife, Inc. at Piper Jaffray Healthcare Conference
LocationNew York City, NY US
Most Recent SEC FilingsMore >>
Filing DateFormFiling GroupDownloads
11/26/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
11/12/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
11/06/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
11/04/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable
11/03/1443,4,5 Download SEC Filing to Word Excel SEC Filing Unavailable Download SEC Filing to Adobe PDF XBRL SEC Filing Unavailable

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.